Physical characteristics of ⁶⁸Ga DOTATATE PET/CT affecting small lesion detectability

Area of Science:

• Nuclear Medicine
• Radiochemistry
• Medical Imaging

Background:

• ⁶⁸Ga DOTATATE PET/CT protocols often mirror ¹⁸F FDG protocols despite differing radiophysical properties.
• Differences in biodistribution and tumor uptake necessitate protocol optimization for ⁶⁸Ga tracers.

Purpose of the Study:

• To assess the impact of scan time and target activity on signal-to-noise ratio (SNR) for various lesion sizes.
• To compare phantom-based findings with clinical ⁶⁸Ga DOTATATE PET/CT data.

Main Methods:

• Phantom studies comparing ⁶⁸Ga and ¹⁸F for recovery coefficients and SNR.
• ⁶⁸Ga phantom scans at varying activities and acquisition times for small (8 mm) and large (≥ 12 mm) targets.
• Analysis of 50 clinical ⁶⁸Ga DOTATATE PET/CT studies (159 tumors) to correlate phantom findings with clinical tumor activity concentrations and SNR.

Main Results:

• ⁶⁸Ga phantoms showed ~87% recovery coefficient and ~65% SNR compared to ¹⁸F.
• For 8 mm targets, increasing scan time (5-15 min) minimally improved SNR (<1 to 1.6) at standard tumor-to-background (T/B) ratio (2.4).
• Increasing T/B from 2.4 to 10.9 dramatically increased SNR (<1 to 22.3), enabling 8 mm lesion visibility even with 1-minute scans.
• Clinical studies demonstrated high SNR (12.5±9.8 and 43.8±49.9) correlating with high SUVmax in hepatic (27.3±29.6) and extrahepatic (41.6±42.8) tumors, respectively.

Conclusions:

• Very high target uptake and T/B ratios can compensate for ⁶⁸Ga's physical limitations.
• High target uptake and T/B are critical for detecting small lesions with ⁶⁸Ga DOTATATE PET/CT.
• Optimizing acquisition parameters based on target characteristics is key for maximizing diagnostic performance.